ライフサイエンスコーパス: excessive daytime sleepiness

1 uate sleep quantity, poor sleep quality, and excessive daytime sleepiness.

2 exhibit insomnia, delayed sleep habits, and excessive daytime sleepiness.

3 ) and without (n=144) complaints of frequent excessive daytime sleepiness.

4 ty to predict important consequences such as excessive daytime sleepiness.

5 rousals, could prove useful in prediction of excessive daytime sleepiness.

6 sturbance may reduce sleep fragmentation and excessive daytime sleepiness.

7 during sleep are a well recognized cause of excessive daytime sleepiness.

8 atients showed high risk for OSAS, 46.3% had excessive daytime sleepiness, 41.5% were positive for bo

9 Excessive daytime sleepiness affected 32% of the patient

10 chronic neurologic disorder characterized by excessive daytime sleepiness and abnormal manifestations

11 ye movement (REM) sleep, is characterized by excessive daytime sleepiness and cataplexy, a loss of mu

12 sy, a debilitating disorder characterized by excessive daytime sleepiness and cataplexy.

13 sorder narcolepsy, which is characterized by excessive daytime sleepiness and cataplexy.

14 l of a human sleep disorder characterized by excessive daytime sleepiness and cataplexy.

15 Therapeutic NCPAP reduces excessive daytime sleepiness and improves self-reported

16 0 x 10(-13)) and between increased levels of excessive daytime sleepiness and increased measures for

17 n SWS, reproducing, respectively, narcolepsy excessive daytime sleepiness and poor sleep quality.

18 r risk benefits, and substantially improving excessive daytime sleepiness and quality of life.

19 way resistance syndrome (UARS) is defined by excessive daytime sleepiness and tiredness, and is assoc

20 We evaluated sleep characteristics, excessive daytime sleepiness, and chronotype using the P

21 vements during sleep are not associated with excessive daytime sleepiness, and therefore appear unlik

22 nts experience increased nocturnal activity, excessive daytime sleepiness, and weight loss.

23 central nervous system disorders, including excessive daytime sleepiness, attention deficit hyperact

24 Excessive daytime sleepiness can be evaluated with both

25 arcolepsy, a sleep disorder characterized by excessive daytime sleepiness, cataplexy, and other patho

26 is a neurological disorder characterized by excessive daytime sleepiness, cataplexy, hypnagonic hall

27 The complaint of excessive daytime sleepiness, commonly encountered in ne

28 The prevalence of excessive daytime sleepiness, defined as an ESS score >/

29 erred for polysomnography with complaints of excessive daytime sleepiness (EDS) and clinically suspec

30 is was tested by exploring the links between excessive daytime sleepiness (EDS) and vulnerability to

31 lness for the treatment of disorders such as excessive daytime sleepiness (EDS) as well as other slee

32 o determine the safety and efficacy of LT on excessive daytime sleepiness (EDS) associated with PD.

33 We assessed whether excessive daytime sleepiness (EDS) at baseline was assoc

34 Excessive daytime sleepiness (EDS) is common and disabli

35 obesity and snoring and between obesity and excessive daytime sleepiness (EDS), although for the mos

36 excessive daytime sleepiness, patients with excessive daytime sleepiness (Epworth Sleepiness Scale s

37 ple, 26% were habitual snorers, 18% reported excessive daytime sleepiness (ESS > or = 11), and 29% we

38 leep disorder narcolepsy is characterized by excessive daytime sleepiness, fragmentation of nighttime

39 Excessive daytime sleepiness has emerged as one of the m

40 here is a distinct differential diagnosis of excessive daytime sleepiness in older adults.

41 al study assessing multiple risk factors for excessive daytime sleepiness in older subjects (mean age

42 servoventilation produces an improvement in excessive daytime sleepiness in patients with Cheyne-Sto

43 sleep fragmentation (SF) appear to underlie excessive daytime sleepiness in patients with sleep apne

44 The etiology of excessive daytime sleepiness in patients with sleep-diso

45 ported sleep duration, insomnia symptoms and excessive daytime sleepiness in the UK Biobank (n = 112,

46 the most common medical disorder that causes excessive daytime sleepiness, increasing the risk for dr

47 ular, eczema associated with atopy, fatigue, excessive daytime sleepiness, insomnia, and only 0 to 3

48 at often are seen by neurologists, including excessive daytime sleepiness, insomnia, narcolepsy, rapi

49 Excessive daytime sleepiness is typically the most frequ

50 L1 and TGFBI in females and WDR27 in males), excessive daytime sleepiness (near AR-OPHN1) and a compo

51 95% CI, 1.11-2.10) (P = .009, I2 = 74%), and excessive daytime sleepiness (OR, 2.27; 95% CI, 1.54-3.3

52 ion (adjusted OR, 2.65; P=0.023), those with excessive daytime sleepiness (OR, 2.51; P=0.037), and th

53 95% CI, 1.14-1.88) (P = .003, I2 = 76%), and excessive daytime sleepiness (OR, 2.72; 95% CI, 1.32-5.6

54 porter availability and fatigue, depression, excessive daytime sleepiness, or rapid eye movement slee

55 Compared with PD patients without excessive daytime sleepiness, patients with excessive da

56 uate sleep quantity, poor sleep quality, and excessive daytime sleepiness, studied according to an a

57 Active treatment reduced excessive daytime sleepiness; the mean Osler change was

58 patic encephalopathy might be unable, due to excessive daytime sleepiness, to accumulate the need/abi